N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine

C25H26F3N5O — CID 71559147

IUPACN-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine
SMILESCCCN(CCc1ccccc1)CCn1cnc2cc(/C=C/c3noc(C(F)(F)F)n3)ccc21
InChIInChI=1S/C25H26F3N5O/c1-2-13-32(14-12-19-6-4-3-5-7-19)15-16-33-18-29-21-17-20(8-10-22(21)33)9-11-23-30-24(34-31-23)25(26,27)28/h3-11,17-18H,2,12-16H2,1H3/b11-9+
InChIKeyXZZCGJCBTKIYJU-PKNBQFBNSA-N
MW469.51 g/mol
LogP5.56
Rot. Bonds10

About N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine

N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine (PubChem CID 71559147) has the molecular formula C25H26F3N5O and a molecular weight of 469.51 g/mol. Its IUPAC name is N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine.

Molecular Properties

Compound NameN-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine
PubChem CID71559147
Molecular FormulaC25H26F3N5O
Molecular Weight469.51 g/mol
Exact Mass469.21
IUPAC NameN-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine
SMILESCCCN(CCc1ccccc1)CCn1cnc2cc(/C=C/c3noc(C(F)(F)F)n3)ccc21
InChIInChI=1S/C25H26F3N5O/c1-2-13-32(14-12-19-6-4-3-5-7-19)15-16-33-18-29-21-17-20(8-10-22(21)33)9-11-23-30-24(34-31-23)25(26,27)28/h3-11,17-18H,2,12-16H2,1H3/b11-9+
InChIKeyXZZCGJCBTKIYJU-PKNBQFBNSA-N
XLogP5.56
TPSA59.98 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds10
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500469.51
LogP ≤ 55.56
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine?
The IUPAC name of N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine (CID 71559147) is N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine.
What is the SMILES notation for N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine?
The canonical SMILES for N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine is CCCN(CCc1ccccc1)CCn1cnc2cc(/C=C/c3noc(C(F)(F)F)n3)ccc21.
What is the InChIKey of N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine?
The InChIKey is XZZCGJCBTKIYJU-PKNBQFBNSA-N. The full InChI is InChI=1S/C25H26F3N5O/c1-2-13-32(14-12-19-6-4-3-5-7-19)15-16-33-18-29-21-17-20(8-10-22(21)33)9-11-23-30-24(34-31-23)25(26,27)28/h3-11,17-18H,2,12-16H2,1H3/b11-9+.
What are the key properties of N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine?
N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine has a molecular weight of 469.51 g/mol, XLogP of 5.56, 10 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-phenylethyl)-N-[2-[5-[(E)-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethenyl]benzimidazol-1-yl]ethyl]propan-1-amine is sourced from PubChem (CID 71559147), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).